Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

Men with early hair loss may have higher health risks similar to women with PCOS.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

Young women with PCOS and no other heart risk factors have normal heart function.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

People with Alopecia Areata are more likely to have prediabetes and obesity.

A pulse-based diet with exercise improved PCOS health more than another diet, but benefits didn't last long-term.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.